Noile-Immune Biotech Inc.

¥79.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4893Healthcare
Country Japan
PE (Fwd) •••
TSR 3Y CAGR (45.31%)
Div yield —
ROE (19.12%)
Biotechnology
Beta (5Y) 0.38
PE TTM —
TSR TTM (49.36%)
Mkt cap ¥3.429B
ROIC (12.75%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥101
27.91%
(71.29%)
Hold 4|1|1|2|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.90
0.97
1.08
1.14
(1.64%)
(0.71%)
15.71%
23.57%
Revenue¥M
155.2
161.9
164.3
169.5
8.16%
9.03%
13.25%
12.64%
Peers (US$21.77M)
Cap (US$)
PE
22.20M
27.32x
20.83M
99.41x
Capital
TTM
5Y
10Y
Leveragex
3.757
0.164
0.166
EBIT/Intx
3.456
0.089
0.078
Own earn%
79.26
(43.20)
(47.91)
Sh yield%
42.75
34.82
30.64
Owners
Insiders/Inst%
11.39
47.26
Short interest%
4.03
SBC / revenue%
3.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
13–17
$1 testx
0.9
Incr. ROIC%
3